The global Lyme disease treatment market size was US$ 737.5 million in 2021. The global Lyme disease treatment market size is estimated to reach US$ 1,524.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4% during the forecast period from 2022 to 2030.
Lyme disease is infectious and caused by the bacteria Borrelia burgdorferi or B. burgdorferi. It is transmitted to humans by a sting from an infected black-legged or deer tick. The tick becomes contaminated after feeding on infected deer, birds, or rats. Some of the most common symptoms such as headache, fever, fatigue, and a distinctive skin rash called erythema migrans.

Factors Affecting Market Growth

- The increased research initiatives to develop a good therapy for Lyme disease are anticipated to drive overall market growth.
- A lack of public understanding concerning the frequency and symptoms of Lyme disease is anticipated to drive the overall market expansion.
- The number of Lyme disease cases is rapidly growing, which has raised the demand for Lyme disease therapy. Thus, driving the overall market expansion.
- The increasing incidence of Lyme disease among individuals worldwide drives the overall market expansion.

Impact Analysis of COVID-19

COVID-19 had a minimal impact on the overall market expansion. Due to its similarity with the symptoms of other infections. Due to this, Lyme disease stays undiagnosed and untreated. Also, there was a significant reduction in the number of patients diagnosed with Lyme disease majorly owing to the reduction in outdoor activities due to lockdown limitations.

Regional Analysis

North America had the highest market share in 2021 and is expected to stay the fastest-growing during the analysis period. Lyme disease is a spirochete-caused multisystem disease. The most frequently reported vector-borne illness in the region is borreliosis, which is caused by Borrelia. 80% of the population in central and eastern Canada potentially were living in Lyme disease hazard zones in 2020. Precise identification and suitable treatment of tick-bitten people are essential factors in reducing the effects of Lyme disease.

Leading Competitors
The prominent players in the global Lyme disease treatment market are:
- Chartwell Pharmaceuticals
- Perrigo Company
- Galaxo SmithKline
- Novartis
- Mayne Pharma
- Sun Pharmaceuticals Industries
- Lupin Pharmaceuticals
- Orion Corporation
- Almirall
- Others
Segmentation Analysis
The global Lyme disease treatment market focuses on Administration Route, Treatment, Distribution Channel, and Region.
Segmentation on the basis of Administration Route
- Oral
- Injectable
- Topical
Segmentation on the basis of Treatment
- Medication
- Tick Removal
Segmentation on the basis of Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online

Segmentation on the basis of Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
- Rest of South America